Silver nanoparticles: synthesis, properties, and therapeutic applications
•AgNPs possess intrinsic therapeutic properties for biomedical applications.•AgNPs are employed in newly emerging applications as photosensitizers/radiosensitizers, antiviral and anticancer agents.•Treatment of a variety of cancers with AgNPs has been documented with AgNPs.•The underlying anticancer...
Saved in:
Published in | Drug discovery today Vol. 20; no. 5; pp. 595 - 601 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Elsevier Ltd
01.05.2015
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | •AgNPs possess intrinsic therapeutic properties for biomedical applications.•AgNPs are employed in newly emerging applications as photosensitizers/radiosensitizers, antiviral and anticancer agents.•Treatment of a variety of cancers with AgNPs has been documented with AgNPs.•The underlying anticancer mechanisms of AgNPs include (1) disruption of cell membranes, and (2) production of reactive oxygen species and Ag+ to damage protein or DNA.•The photosensitizing mechanism of AgNPs is based on nonradiative decay converting photo energy to thermal energy.
Silver nanoparticles (AgNPs) have been widely used in biomedical fields because of their intrinsic therapeutic properties. Here, we introduce methods of synthesizing AgNPs and discuss their physicochemical, localized surface plasmon resonance (LSPR) and toxicity properties. We also review the impact of AgNPs on human health and the environment along with the underlying mechanisms. More importantly, we highlight the newly emerging applications of AgNPs as antiviral agents, photosensitizers and/or radiosensitizers, and anticancer therapeutic agents in the treatment of leukemia, breast cancer, hepatocellular carcinoma, lung cancer, and skin and/or oral carcinoma. |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1 Current address: Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD 20892, USA |
ISSN: | 1359-6446 1878-5832 |
DOI: | 10.1016/j.drudis.2014.11.014 |